Jiao Y, Chen X, Liu L, Lu Y, Gao M, Wang Q, et al
The collaboration included our most advanced preclinical metabolic program focused on developing an oral small molecule agonist to the GIP receptor
Glutathione is one of the primary elements in our IV treatment technique, albeit each solution is somewhat different
Clinical outcomes with GLP-1 receptor agonists in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
Myristoylation-dependent palmitoylation of cyclin Y modulates long-term potentiation and spatial learning
Available in injectable and tablet form, this drug works by mimicking a hormone called glucagon-like peptide 1 (GLP-1) which the body naturally produces to regulate hunger and blood sugar levels